Event
Reshape Biotech raises $20 million Series A
Reshape Biotech raised a $20 million Series A led by Astanor Ventures to expand its laboratory-automation platform and U.S. operations.
Evidence notes
- Astanor Ventures led the round, with R7, ACME, Y Combinator, Nicholas Francis and Per Falholt also participating.
- Reshape said the financing would support U.S. expansion and global hiring as it scaled robotic imaging and AI analysis for biological research.
- The company reported deployments with institutions including Syngenta and the University of Oxford and said its platform was saving more than 500,000 hours of manual work annually.
Company context
Reshape Biotech combines automated laboratory imaging hardware with AI analysis and workflow software for microbiology research and quality control.
Context
- Company
- Reshape Biotech
- Segment
- Lab Automation
- Event type
- Funding
- Added to Korthos
- Jul 17, 2026
- Geography
- Copenhagen · Denmark